Learning Curve of Robotic Pancreaticoduodenectomy with Portal–Superior Mesenteric Vein Resection for Pancreatic Cancers

<b>Background</b>: Pancreaticoduodenectomy (PD) with portal-superior mesenteric vein (PV-SMV) resection is increasingly performed in borderline-resectable periampullary cancer. While conventional PD is the reference standard, robotic PD (RPD) may improve operative ergonomics and recovery; its performance and learning curve in PV-SMV resection remain unclear. <b>Materials and Methods</b>: We retrospectively reviewed consecutive patients undergoing PD with PV-SMV resection at a single tertiary center by a single surgeon (July 2016-September 2022). Twenty-seven patients met the inclusion criteria and were grouped as conventional PD (<i>n</i> = 14) or RPD (<i>n</i> = 13). To assess the learning curve, RPD cases were stratified as early (cases 1-3) versus late (cases 4-13). Primary outcomes were operative time and blood loss; secondary outcomes included 90-day morbidity/mortality, R0 margin, lymph node yield, length of stay, readmission, and overall survival. <b>Results</b>: Baseline characteristics were comparable between conventional PD and RPD. Median operative time was longer with RPD vs. conventional PD (624.0 [IQR 579.0-794.0] vs. 529.5 [456.5-636.5] mins; <i>p</i> = 0.024). Median blood loss trended lower with RPD (350.0 [200.0-1950.0] vs. 1455.0 [630.0-2940.0] mL; <i>p</i> = 0.254). Rates of clinically relevant complications (including POPF, DGE, and hemorrhage), R0 resection (69% vs. 64%), lymph node retrieval, length of stay, 90-day readmission, 90-day mortality, and overall survival were similar between conventional PD and RPD. Within RPD, operative time and blood loss improved from the early to late phases (794.0 → 601.5 min; 1950.0 → 275.0 mL), consistent with a learning-curve effect, though not statistically significant in this small cohort. <b>Conclusions</b>: In selected patients, RPD with PV-SMV resection is feasible and achieves oncologic and short-term clinical outcomes comparable to conventional PD, with evidence of efficiency gains as experience accrues. These findings support structured training and case accumulation for the safe adoption of complex robotic pancreatic surgery.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-11-11
DOI
https://doi.org/10.3390/jcm14227986
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Learning Curve of Robotic Pancreaticoduodenectomy with Portal–Superior Mesenteric Vein Resection for Pancreatic Cancers

Sheng-Yang Huang, Yi‐Ju Chen, Yung-Hsien Chen, Hui-Chen Lin et al.
Journal of Clinical Medicine
Pancreatic and Hepatic Oncology Research
article

Learning Curve of Robotic Pancreaticoduodenectomy with Portal–Superior Mesenteric Vein Resection for Pancreatic Cancers

Sheng-Yang Huang, Yi‐Ju Chen, Yung-Hsien Chen, Hui-Chen Lin, Peng-Yu Ku
article en

Abstract

<b>Background</b>: Pancreaticoduodenectomy (PD) with portal-superior mesenteric vein (PV-SMV) resection is increasingly performed in borderline-resectable periampullary cancer. While conventional PD is the reference standard, robotic PD (RPD) may improve operative ergonomics and recovery; its performance and learning curve in PV-SMV resection remain unclear. <b>Materials and Methods</b>: We retrospectively reviewed consecutive patients undergoing PD with PV-SMV resection at a single tertiary center by a single surgeon (July 2016-September 2022). Twenty-seven patients met the inclusion criteria and were grouped as conventional PD (<i>n</i> = 14) or RPD (<i>n</i> = 13). To assess the learning curve, RPD cases were stratified as early (cases 1-3) versus late (cases 4-13). Primary outcomes were operative time and blood loss; secondary outcomes included 90-day morbidity/mortality, R0 margin, lymph node yield, length of stay, readmission, and overall survival. <b>Results</b>: Baseline characteristics were comparable between conventional PD and RPD. Median operative time was longer with RPD vs. conventional PD (624.0 [IQR 579.0-794.0] vs. 529.5 [456.5-636.5] mins; <i>p</i> = 0.024). Median blood loss trended lower with RPD (350.0 [200.0-1950.0] vs. 1455.0 [630.0-2940.0] mL; <i>p</i> = 0.254). Rates of clinically relevant complications (including POPF, DGE, and hemorrhage), R0 resection (69% vs. 64%), lymph node retrieval, length of stay, 90-day readmission, 90-day mortality, and overall survival were similar between conventional PD and RPD. Within RPD, operative time and blood loss improved from the early to late phases (794.0 → 601.5 min; 1950.0 → 275.0 mL), consistent with a learning-curve effect, though not statistically significant in this small cohort. <b>Conclusions</b>: In selected patients, RPD with PV-SMV resection is feasible and achieves oncologic and short-term clinical outcomes comparable to conventional PD, with evidence of efficiency gains as experience accrues. These findings support structured training and case accumulation for the safe adoption of complex robotic pancreatic surgery.

Journal of Clinical MedicineVol. 14(22)
National Yang Ming Chiao Tung University (TW), National Chung Hsing University (TW), Taichung Veterans General Hospital (TW)
Chang Bing Show Chwan Memorial Hospital
Openalex Percentile: Top 53%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.